Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

  • Quoted phrase not found.
1.

Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study.

Madsen CV, Bundgaard H, Rasmussen ÅK, Sørensen SS, Petersen JH, Køber L, Feldt-Rasmussen U, Petri H.

Scand Cardiovasc J. 2017 Aug;51(4):207-216. doi: 10.1080/14017431.2017.1332383. Epub 2017 May 25.

PMID:
28545342
2.

Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.

Ntusi NA, Shaboodien G, Badri M, Gumedze F, Mayosi BM.

Cardiovasc J Afr. 2016 May/Jun;27(3):152-158. doi: 10.5830/CVJA-2015-075.

3.

Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography.

Peyrou J, Réant P, Reynaud A, Cornolle C, Dijos M, Rooryck-Thambo C, Landelle M, Montaudon M, Laurent F, Roudaut R, Lafitte S.

Int J Cardiovasc Imaging. 2016 Sep;32(9):1379-1389. Epub 2016 Jun 20.

PMID:
27324645
4.

Transthyretin Cardiac Amyloidosis in Black Americans.

Shah KB, Mankad AK, Castano A, Akinboboye OO, Duncan PB, Fergus IV, Maurer MS.

Circ Heart Fail. 2016 Jun;9(6):e002558. doi: 10.1161/CIRCHEARTFAILURE.115.002558. Review.

5.

Combined Heart and Liver Transplantation: The Cedars-Sinai Experience.

Reich HJ, Awad M, Ruzza A, De Robertis MA, Ramzy D, Nissen N, Colquhoun S, Esmailian F, Trento A, Kobashigawa J, Czer LS.

Transplant Proc. 2015 Nov;47(9):2722-6. doi: 10.1016/j.transproceed.2015.07.038.

PMID:
26680081
6.

Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.

Jensen MK, Havndrup O, Christiansen M, Andersen PS, Axelsson A, Køber L, Bundgaard H.

Int J Cardiovasc Imaging. 2015 Dec;31(8):1511-8. doi: 10.1007/s10554-015-0723-x. Epub 2015 Aug 1.

PMID:
26231341
7.

Recognition and significance of pathological T-wave inversions in athletes.

Schnell F, Riding N, O'Hanlon R, Axel Lentz P, Donal E, Kervio G, Matelot D, Leurent G, Doutreleau S, Chevalier L, Guerard S, Wilson MG, Carré F.

Circulation. 2015 Jan 13;131(2):165-73. doi: 10.1161/CIRCULATIONAHA.114.011038. Epub 2014 Nov 10.

8.

Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.

Nomura A, Konno T, Fujita T, Tanaka Y, Nagata Y, Tsuda T, Hodatsu A, Sakata K, Nakamura H, Kawashiri MA, Fujino N, Yamagishi M, Hayashi K.

Circ J. 2015;79(1):136-43. doi: 10.1253/circj.CJ-14-0822. Epub 2014 Nov 7.

9.

Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.

Lopes LR, Syrris P, Guttmann OP, O'Mahony C, Tang HC, Dalageorgou C, Jenkins S, Hubank M, Monserrat L, McKenna WJ, Plagnol V, Elliott PM.

Heart. 2015 Feb;101(4):294-301. doi: 10.1136/heartjnl-2014-306387. Epub 2014 Oct 28.

10.

Atlas of the clinical genetics of human dilated cardiomyopathy.

Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R, Feng Z, Müller S, Kayvanpour E, Vogel B, Sedaghat-Hamedani F, Lim WK, Zhao X, Fradkin D, Köhler D, Fischer S, Franke J, Marquart S, Barb I, Li DT, Amr A, Ehlermann P, Mereles D, Weis T, Hassel S, Kremer A, King V, Wirsz E, Isnard R, Komajda M, Serio A, Grasso M, Syrris P, Wicks E, Plagnol V, Lopes L, Gadgaard T, Eiskjær H, Jørgensen M, Garcia-Giustiniani D, Ortiz-Genga M, Crespo-Leiro MG, Deprez RH, Christiaans I, van Rijsingen IA, Wilde AA, Waldenstrom A, Bolognesi M, Bellazzi R, Mörner S, Bermejo JL, Monserrat L, Villard E, Mogensen J, Pinto YM, Charron P, Elliott P, Arbustini E, Katus HA, Meder B.

Eur Heart J. 2015 May 7;36(18):1123-35a. doi: 10.1093/eurheartj/ehu301. Epub 2014 Aug 27.

PMID:
25163546
11.

Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy.

Bratt EL, Östman-Smith I.

Cardiol Young. 2015 Mar;25(3):501-10. doi: 10.1017/S1047951114000237. Epub 2014 Mar 10.

12.

Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.

Forsey J, Benson L, Rozenblyum E, Friedberg MK, Mertens L.

J Am Soc Echocardiogr. 2014 Feb;27(2):215-21. doi: 10.1016/j.echo.2013.10.012. Epub 2013 Dec 8.

PMID:
24325958
13.

A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations.

Lopes LR, Rahman MS, Elliott PM.

Heart. 2013 Dec;99(24):1800-11. doi: 10.1136/heartjnl-2013-303939. Epub 2013 May 14. Review.

PMID:
23674365
14.

Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy.

Klarich KW, Attenhofer Jost CH, Binder J, Connolly HM, Scott CG, Freeman WK, Ackerman MJ, Nishimura RA, Tajik AJ, Ommen SR.

Am J Cardiol. 2013 Jun 15;111(12):1784-91. doi: 10.1016/j.amjcard.2013.02.040. Epub 2013 Mar 27. Erratum in: Am J Cardiol. 2013 Oct 15;112(8):1271.

PMID:
23540548
15.

Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy.

Fujita E, Nakanishi T, Nishizawa T, Hagiwara N, Matsuoka R.

Heart Vessels. 2013 Nov;28(6):785-94. doi: 10.1007/s00380-013-0332-3. Epub 2013 Mar 14.

16.

The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.

Olde Nordkamp LR, Wilde AA, Tijssen JG, Knops RE, van Dessel PF, de Groot JR.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):91-100. doi: 10.1161/CIRCEP.112.975268. Epub 2012 Dec 29.

17.

Progressive breathlessness in an Afro Caribbean hypertensive subject.

Dwivedi G, MacFadyen RJ, Varma C, Sharma V, Neil D, Steeds RP.

Cardiol J. 2012;19(6):646-9.

18.

Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing.

Jensen MK, Havndrup O, Christiansen M, Andersen PS, Diness B, Axelsson A, Skovby F, Køber L, Bundgaard H.

Circulation. 2013 Jan 1;127(1):48-54. doi: 10.1161/CIRCULATIONAHA.111.090514. Epub 2012 Nov 28.

19.

Genetic variations in hypoxia response genes influence hypertrophic cardiomyopathy phenotype.

Alkon J, Friedberg MK, Manlhiot C, Manickaraj AK, Kinnear C, McCrindle BW, Benson LN, Addonizio LJ, Colan SD, Mital S.

Pediatr Res. 2012 Dec;72(6):583-92. doi: 10.1038/pr.2012.126. Epub 2012 Sep 24.

PMID:
23007030
20.

Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry.

Wilkinson JD, Lowe AM, Salbert BA, Sleeper LA, Colan SD, Cox GF, Towbin JA, Connuck DM, Messere JE, Lipshultz SE.

Am Heart J. 2012 Sep;164(3):442-8. doi: 10.1016/j.ahj.2012.04.018. Epub 2012 Aug 9.

PMID:
22980313

Supplemental Content

Loading ...
Support Center